pharma manufacturing

India’s PLI Scheme: $5B Pharma Investments Surge A hand interacting with a holographic display showing a rising bar graph and a map of India, overlaid on a pharmaceutical manufacturing line.

A hand interacting with a holographic display showing a rising bar graph and a map of India, overlaid on a pharmaceutical manufacturing line.

India’s PLI Scheme: $5B Pharma Investments Surge

sivam March 20, 2026

India's PLI scheme for pharmaceuticals doubles its commitment, attracting ₹41,943 crore ($5B) in investments. Boosts domestic pharma...

Natco Pharma Launches Semaglutide in India Post-Patent Semaglutide medicine boxes, vials, and injection pens on a table with an India map and factory silhouettes in the background.

Semaglutide medicine boxes, vials, and injection pens on a table with an India map and factory silhouettes in the background.

Natco Pharma Launches Semaglutide in India Post-Patent

sivam March 20, 2026

Natco Pharma launches affordable semaglutide injection in India after patent expiry, increasing access to diabetes and weight...

Indian Pharma: Input Price Caps Urged Amid Cost Surge An abstract image depicting India's pharmaceutical industry facing surging costs. It shows a map of India with "HDMA"

An abstract image depicting India's pharmaceutical industry facing surging costs. It shows a map of India with "HDMA"

Indian Pharma: Input Price Caps Urged Amid Cost Surge

sivam March 19, 2026

Indian pharma firms seek input price controls as global conflicts disrupt supply chains, causing a cost surge....

India’s API Exports Surge: Boosting Self-Reliance in Pharma An abstract representation of India's map with upward arrows and a rising bar graph, signifying growth in API exports.

An abstract representation of India's map with upward arrows and a rising bar graph, signifying growth in API exports.

India’s API Exports Surge: Boosting Self-Reliance in Pharma

sivam March 10, 2026

India's API exports hit a record in FY25, surpassing imports. This surge, fueled by the PLI scheme,...

Genexis Slashes Protein Production Costs 10X for Pharma A modern pharmaceutical manufacturing facility with large bioreactors, scientists in clean suits, and a robotic arm with glowing chemicals, demonstrating 10x cost reduction.

A modern pharmaceutical manufacturing facility with large bioreactors, scientists in clean suits, and a robotic arm with glowing chemicals, demonstrating 10x cost reduction.

Genexis Slashes Protein Production Costs 10X for Pharma

sivam March 10, 2026

Genexis revolutionizes pharma manufacturing, cutting cell culture protein costs tenfold with engineered microbes. Learn how they're transforming...

Pharma Exporters Face Soaring Costs & Supply Chain Woes A modern pharmaceutical factory at dusk with shipping containers full of medical products and an overlay of rising financial graphs.

A modern pharmaceutical factory at dusk with shipping containers full of medical products and an overlay of rising financial graphs.

Pharma Exporters Face Soaring Costs & Supply Chain Woes

sivam March 9, 2026

Indian pharma exporters struggle with rising freight costs and supply chain disruptions due to West Asia tensions....

Cipla USA Recalls Nilotinib Anti-Cancer Drug Due to Defect A gloved hand holds a vial of Nilotinib, with a pharmaceutical manufacturing facility in the background.

A gloved hand holds a vial of Nilotinib, with a pharmaceutical manufacturing facility in the background.

Cipla USA Recalls Nilotinib Anti-Cancer Drug Due to Defect

sivam March 8, 2026

Cipla USA recalls Nilotinib anti-cancer capsules (150mg and 200mg) due to a manufacturing defect, as confirmed by...

Semaglutide vs. Tirzepatide: Novo Nordisk Gains in India A scientific image depicting Semaglutide, Novo Nordisk, Eli Lilly, and an upward arrow indicating market competition in India.

A scientific image depicting Semaglutide, Novo Nordisk, Eli Lilly, and an upward arrow indicating market competition in India.

Semaglutide vs. Tirzepatide: Novo Nordisk Gains in India

sivam March 8, 2026

Novo Nordisk's semaglutide is rapidly gaining ground in India's anti-obesity market, challenging Eli Lilly's tirzepatide. Discover how...

India to Lead Global Homoeopathy Market with Quality Certifications India map with glowing nodes, global map, pharmaceutical equipment, and quality certification logos (GMP, ISO 9001, AYUSH Premium).

India map with glowing nodes, global map, pharmaceutical equipment, and quality certification logos (GMP, ISO 9001, AYUSH Premium).

India to Lead Global Homoeopathy Market with Quality Certifications

sivam March 8, 2026

India is set to dominate the global homoeopathy market, driven by clinical expertise, strong practitioner networks, and...

Cipla Recalls Cancer Drug in US Due to Manufacturing Flaw Two scientists in a sterile lab, with a "RECALL" box in the foreground and a robot arm spilling pills.